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Abstract
Borna disease virus (BDV) is one of the potential infectious agents involved in the development of central nervous system (CNS) diseases.
Neurons and astrocytes are the main targets of BDV infection, but little is known about the roles of BDV infection in the biological effects of
astrocytes. Here we reported that BDV inhibits the activation of inducible nitric oxide synthase (iNOS) in murine astrocytes induced by bacterial
LPS and PMA. To determine which protein of BDV is responsible for the regulation of iNOS expression, we co-transfected murine astrocytes with
reporter plasmid iNOS-luciferase and plasmid expressing individual BDV proteins. Results from analyses of reporter activities revealed that only
the phosphoprotein (P) of BDV had an inhibitory effect on the activation of iNOS. In addition, P protein inhibits nitric oxide production through
regulating iNOS expression. We also reported that the nuclear factor kappa B (NF-κB) binding element, AP-1 recognition site, and interferon-
stimulated response element (ISRE) on the iNOS promoter were involved in the repression of iNOS gene expression regulated by the P protein.
Functional analysis indicated that sequences from amino acids 134 to 174 of the P protein are necessary for the regulation of iNOS. These data
suggested that BDV may suppress signal transduction pathways, which resulted in the inhibition of iNOS activation in astrocytes.
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Borna disease virus (BDV), a nonsegment negative-strand
RNAvirus, belongs to the family Bornavirida, characterized by
low productivity, neurotropism, and nuclear localization of
transcription and replication products (Jordan and Lipkin, 2001;
Tomonaga et al., 2002). It has been shown that BDV can cause
diseases of central nervous system (CNS) in sheep and horses
originally. Recent studies suggested that BDV infection even
occurs in a wide range of vertebrate species (Rott and Becht,
1995). Epidemiological researchers have demonstrated a higher
prevalence of BDV infection in human psychiatric patients than
in controls (Bode and Ludwig, 2003; Miranda et al., 2006).
However, more recent reports indicated that BDV may not play⁎ Corresponding author. Fax: +86 27 68754592.
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doi:10.1016/j.virol.2007.04.031significant roles in human health (Wolff et al., 2006; Durrwald
et al., 2007).
The phosphoprotein (P) of BDV can bind to the N, X, and
L proteins of the virus and regulate the active polymerase
complex of BDV (Poenisch et al., 2004; Schneider et al., 2004;
Schneider, 2005). It has been reported that P protein can be
phosphorated by protein kinase Cє and casein kinase II
(Schwemmle et al., 1997). The P protein is abundantly
expressed in infected animal brains and directly binds to a
multifunctional protein (HMGB-1) and inhibits the functions of
HMGB-1 in cultured neural cells (Kamitani et al., 2001; Zhang
et al., 2003). In addition, expression of BDV P protein resulted
in the induction of behavioral and neurological abnormalities in
transgenic mice (Kamitani et al., 2003). This viral protein can
also counteract TBK-1-dependent IFN-β expression in cells
and, hence, the establishment of an antiviral state (Unterstab
et al., 2005).
The inducible isoform of nitric oxide synthase (iNOS) is not
typically expressed in CNS under physiological conditions, but it
Fig. 1. Determination of the roles of BDV in the regulation of iNOS mRNA and
its protein expression. C6 cells infected with BDV strain H1766 or mock
infected were treated with LPS and PMA. (A) Total mRNAwas prepared from
treated C6 cells and used for semi-quantitative RT-PCR using primers specific
for P, iNOS, and β-actin genes, respectively. (B) Protein extracts were prepared
from treated C6 cells and used for Western blot analysis using antibodies
specific to P, iNOS, and β-actin proteins, respectively.
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in many neurological disorders (Kleinert et al., 2003). It is
recently reported that neuronal nitric oxide synthase plays a key
role in CNS demyelination (Linares et al., 2006). Glial cells are
the major places of iNOS expression and consequently, high-
output production of nitric oxide (NO), a product of iNOS, in the
CNS. Overproduction of NOmay lead to the generation of highly
reactive species, such as peroxynitrite and stable nitrosothiols that
may cause irreversible cell damage in pathological conditions
(Kleinert et al., 2003). Several studies have suggested that NO
may be involved in the pathogenesis of various neuroinflamma-
tory/degenerative diseases. Increased concentrations of NO in the
CNS are usually attributed to an increase in the iNOS usually
produced by inflammatory cells. Transcriptional regulation of
iNOS gene is complex and not fully understood, but appears to be
regulated in part by NF-κB (Davis et al., 2005).
In animal model, the mechanism of impaired immune
responses by the virus has not been fully determined. In this
report, we studied the effects of BDV and its P protein on the
regulation of iNOS gene. The roles of NF-κB, ISRE, and AP-1
binding elements in the expression of iNOS gene regulated by
the P protein were also investigated. The potential molecular
mechanisms involved in the effects of the P protein of BDVon
the regulation of iNOS gene expression and therefore the
production of NO were also discussed.
Results
BDV represses the expression of iNOS mRNA and protein
induced by LPS and PMA
In order to investigate the roles of BDV in the regulation of
iNOS expression activated by LPS and PMA, we examined the
effects of BDVon the activation of iNOS mRNA and its protein
in murine astrocytes C6 by RT-PCR and Western blot analyses.
Total mRNA and protein extracts were prepared from C6 cells
infected with BDV or mock-infected and treated with bacterial
LPS and PMA. RT-PCR results showed that the levels of iNOS-
specific mRNAwere significantly reduced in cells infected with
BDV comparing to that of mock-infected cells (Fig. 1A).
Similar results were obtained from Western blot analyses of
iNOS protein, which showed that BDV inhibited the levels of
iNOS protein expression activated by LPS and PMA (Fig. 1B).
To ensure BDV protein is expressed in infected cells, the
expression status the BDV P gene was used as an indicator.
Results indicated that both P gene mRNA (Fig. 1A) and its
protein (Fig. 1B) were expressed in C6 cells infected with BDV,
but not in mock-infected cells. Results also showed that the
levels of β-actin mRNA (Fig. 1A) and its protein (Fig. 1B)
remained relatively unchanged in the presence or absence of
BDV (Figs. 1A and B, lanes 1 and 2).
P protein inhibits the activation of iNOS promoter induced by
LPS and PMA
To study the effects of BDV proteins on iNOS gene ex-
pression, we investigated effects of three major gene products(P, N, and P10) of the virus on the regulation of the iNOS gene
promoter activated by LPS and PMA. C6 rat glioma cells were
co-transfected with reporter plasmid (pGL-iNOS-Luc) contain-
ing the luciferase reporter gene driven by the iNOS gene
promoter and control plasmid (pCDNA-3) or three individual
plasmids (pCDNA-P, pCDNA-N, pCDNA-P10) expressing the
P, N, and P10 protein, respectively. After 24 h post-
transfection, cells were treated with bacterial LPS and PMA.
For additional 24 h, the effect of each viral protein on the
expression of the iNOS gene activated by LPS and PMA was
determined by the measurement of luciferase activity in
transfected cells. Results revealed that among the three
candidate proteins tested, only the P protein of BDV showed
significant inhibitory effect on the activation of iNOS induced
by LPS and PMA (Fig. 2A).
To determine if the effect of P protein on iNOS promoter
expression was specific, C6 cells were co-transfected with the
reporter plasmid and plasmid pCDNA-P at different concentra-
tions, respectively. After the treatment of bacterial LPS and
PMA for additional 24 h, cells were analyzed for luciferase
activity. Results clearly showed that the levels of iNOS
promoter activity were gradually decreased as the concentration
of P protein increased (Fig. 2B), which indicated that the
inhibitory effect of P protein on the activation of iNOS promoter
regulated by LPS and PMA was in a P protein concentration-
dependent fashion.
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inhibition of iNOS gene expression regulated by the P protein
Transcriptional regulation of the inducible nitric oxide
synthase gene is complex and not fully understood. We next
attempted to determine the roles of cis-regulatory elements of
the iNOS promoter on the function of BDV P protein in
regulating the iNOS expression activated by LPS and PMA. C6
cells were transfected with pcDNA-P or pcDNA-3 and the
reporter plasmids in which the luciferase gene was under thecontrol of NF-κB binding element, AP1 binding element, ISRE,
or TK promoter, respectively. After the treatment with LPS and
PMA, cell extracts were assayed for luciferase activity. Results
showed that the P protein could reduce the level of luciferase
activity by about 3-folds under the control of NF-κB, ISRE, or
AP1 binding element, respectively (Fig. 2C). However, the
level of luciferase activity was remained relatively unchanged in
the presence or absence of the P protein (Fig. 2C) indicating P
protein played no role in the regulation of the constitutive
promoter (TK). These results suggested that NF-κB, ISRE, and
AP1 binding elements are involved in the expression of iNOS
gene expression regulated by the BDV P protein in C6 cells.
P protein represses the expression of both iNOS mRNA and its
protein
In order to further confirm the roles of BDV P protein in the
regulation of iNOS expression activated by LPS and PMA, we
examined the effects of iNOS gene mRNA and iNOS protein
expression by RT-PCR and Western blot analysis, respectively.
C6 cells stably carrying plasmid pCDNA-P or control plasmid
pCDNA-3 were treated with or without LPS and PMA. Total
mRNA and protein extracts were prepared respectively and
specific mRNA and proteins were determined.
RT-PCR results showed that the level of iNOS-specific
mRNA was increased in cells treated with LPS and PMA (Fig.
3A, lane 1) comparing to that of untreated control (Fig. 3A, lane
2). However, in the presence of P protein the levels of iNOS-
specific mRNAwere significantly reduced (Fig. 3A, lanes 3 and
4). Results fromWestern blot analyses (Fig. 3B) were consistent
with RT-PCR results (Fig. 3A). iNOS protein level was increased
under the condition of LPS and PMA treatment (Fig. 3B, lane 1)
comparing to that of untreated control (Fig. 3B, lane 2). In
addition, P protein significantly inhibited the levels of iNOS
protein produced (Fig. 3B, lanes 3 and 4). As endogenous
controls, the levels of β-actin mRNA and its protein remained
unchanged in all conditions. Results indicated that both iNOS
mRNA and protein expression were activated by LPS and PMA,
but such activation was inhibited by the P protein.
Production of nitrite is repressed by the P protein
Considering the facts that the production of nitric oxide (NO)
was catalyzed by the enzyme iNOS and that nitrite is commonlyFig. 2. Analysis of effects of the P protein of BDVon the activation of promoters
induced by LPS and PMA. (A) C6 cells were co-transfected with plasmids
(pcDNA-P, pcDNA-N, and pcDNA-X) expressing the P, N, and p10 proteins of
BDV, respectively, and reporter plasmid (pGL-iNOS-luc) containing the iNOS
promoter-luciferase fusion gene. (B) C6 cells were co-transfected with plasmid
pcDNA-P at the concentration as indicated and the reporter pGL-iNOS-luc. (C)
C6 cell were transfected with control vector or plasmid expressing the P protein
and the reporter plasmids in which the luciferase reporter gene is under the
control of AP1 binding element (pAp1-luc), NF-κB binding element (pNF-κB-
luc), ISRE (pISRE-luc), and TK promoter (pRL-TK), respectively. 24 h post-
transfection, cells were treated with bacterial LPS and PMA for additional 24 h.
Cell extracts of treated C6 cell were prepared and assayed for luciferase activity.
β-gal normalized reporter activation in transfected cells was expressed in
comparison with values obtained from mock-transfected cells.
Fig. 4. Measurement of nitrite production regulated by P protein in C6 cells. C6
cells were transfected with plasmid expressing the P protein or control plasmid
and then incubated in serum-free DMEM in the presence or absence of PMA
(400 ng/ml) and LPS (500 ng/ml). After 24 h of incubation, nitrite concentration
in the supernatants was measured as described in the Materials and methods
section. Each data is the mean of duplicate determinations.
Fig. 3. Determination of the effects of P protein on the expression of iNOS
mRNA and protein. C6 cells stably carrying the control plasmid (pcDNA3) or
plasmid expressing the BDV P protein (pcDNA-P) were treated with LPS and
PMA. (A) Total mRNAwas prepared from treated C6 cells and used for semi-
quantitative RT-PCR using primers specific for P, iNOS, and β-actin genes,
respectively. (B) Protein extracts were prepared from treated C6 cells and used
for Western blot analysis using antibodies to P, iNOS, and β-actin proteins,
respectively.
Fig. 5. Identification of domains of BDV P protein required for the regulation of
iNOS expression. (A) Schematic representations of deletion mutants of P
proteins. The numbers indicate amino acid residuals located in the P protein. (B)
C6 cells were co-transfected with luciferase reporter plasmid pGL-iNOS-luc and
plasmids expressing individual truncated P proteins as indicated or pcDNA3
plasmid as negative control. 24 h post-transfection, cells were treated with LPS
and PMA for additional 24 h. Cell extracts were prepared and then assayed for
luciferase activity. The values are expressed as means plus standard errors of the
mean.
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next performed an experiment to determine the roles of P
protein in the regulation of nitrate production. C6 cells stably
carrying plasmid pCDNA-P or control plasmid pCDNA-3 were
treated with or without LPS and PMA. The production of nitrite
in treated C6 cells were then determined.
Results showed that the concentration of nitrite was lower
(1.93 μM) in the presence of P protein (Fig. 4, lane 1) than that
(2.89 μM) in the absence of the viral protein (Fig. 4, lane 2) in
C6 cells without the treatment of PMA and LPS. The production
of nitrite was stimulated in C6 cells when treated with PMA and
LPS (Fig. 4, lanes 3 and 4). However, we observed that the
concentration of nitrite was reduced from 9.38 μM in the
absence of P protein (Fig. 4, lane 4) to 5.21 μM in the presence
of the P protein (Fig. 4, lane 3). These data suggested that the P
protein of BDV inhibited nitrite production through the
regulation of iNOS expression.
Amino acids from 135 to 174 of the P protein are essential for
the inhibition of iNOS activation
The P protein of BDV consists of 201 amino acids. To
functionally analyze this protein, we generated 5 deletion
mutants of the P gene that expressing 5 truncated P proteins
(P▵N1, P▵N2, P▵N3, P▵C1, and P▵C2), respectively (Fig.
5A). The 5 mutants P genes were then inserted into theexpressing vector to yield 5 plasmids (pcDNA-P▵N1, pcDNA-
P▵N2, pcDNA-P▵N3, pcDNA-P▵C1, and pcDNA-P▵C2).
The ability of each P protein in the inhibition of iNOS gene
activation were determined by co-transfection of C6 cells with
the reporter plasmid and plasmid pcDNA-P or each of the
mutant plasmids, respectively, and then treated with LPS and
PMA.
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activation of iNOS promoter induced by LPS and PMA was
inhibited by the wild-type P protein and 4 truncated P proteins,
including ΔN1 (lacking N terminus 55aa), ΔN2 (lacking N
terminus 86aa), ΔN3 (lacking N terminus 134aa), and ΔC2
(lacking C terminus 27aa), respectively (Fig. 5B). However, the
truncated P protein ΔC1 (lacking C-terminal 67aa) was unable
to inhibit the expression of iNOS promoter activated by LPS
and PMA (Fig. 5B). These results suggested that the region
containing amino acids from 134 to 174 of P protein are
necessary for the fully function of the viral protein in the
inhibition of the iNOS promoter expression activated by
bacterial LPS and PMA.
Discussion
Borna disease (BD) is one kind of immune-mediated
diseases. Histopathology examination of rats with acute BD
revealed intense mononuclear inflammation of the CNS. It has
been reported that mRNA levels of tumor necrosis factor alpha
(TNF-α), interleukin 1-alpha (IL-1α), interleukin 6 (IL-6), and
gamma interferon (IFN-γ) were increased in brains of BDV-
infected rats (Shankar et al., 1992). These cytokines can prime
macrophages and glia cells for the production of inducible
reactive oxygen intermediates and reactive nitrogen intermedi-
ates (Akaike et al., 1995; Zheng et al., 1993). There was no
detectable alteration in the expression of NOS genes in BDV-
infected cerebellar slice cultures (Friedl et al., 2004). BDV can
induce severe neurological disorder in Lewis rats and MRL
mice in the absence of inducible NO synthase (Hausmann et al.,
2004). So far, little was known about the effects of BDV
infection on inducible nitric oxide synthase (iNOS) expression
in astrocytes.
In this study, we report that BDV represses the expression of
iNOS mRNA and protein induced by bacterial LPS and PMA in
infected C6 glia cells (Fig. 1). Furthermore, the P protein of
BDV is responsible for the inhibition of iNOS promoter
activation (Fig. 2), repression of iNOS RNA and protein
synthesis (Fig. 3), and reduction of NO production (Fig. 4)
induced by PMA and LPS in transfected C6 cells. It has been
reported that iNOS mRNAwas not detected in normal rat brain
but was identified in BDV-infected rat brain and that iNOS-
positive cells morphologically were monocytes/macropholopy,
not astrocytes (Zheng et al., 1993). Our results are consistent
with these earlier findings. One of the explanations for iNOS
not being expressed in astrocytes is that the P protein of BDV
inhibits the activation of iNOS in this cell type.
Expression of iNOS and other inflammatory cytokines is
tightly controlled by the latent transcription factor NF-κB, IFN-
stimulated factor, and AP-1 (Gupta and Kone, 1999; Syapin et
al., 1999). In addition, BDV infection did not lead to NF-κB
activation in CRL cell cultures (Bourteele et al., 2005) implying
NF-κB activation may be repressed in BDV-infected cells. We
found that the P protein of BDV inhibits the activation of NF-κB
binding element, and therefore may repress NF-κB activity
(Fig. 2C). This finding is similar with other reports that many
RNA viruses, such as hepatitis C virus (HCV), interfere withNF-κB activation and inhibit COX-2 expression. Recently, it
was reported that P protein could be phosphorylated by TBK-1
both in vivo and in vitro, and it might act as a viral decoy
substrate for TBK-1, thus inhibited the expression of interferon
β. In addition, P protein could repress ISRE-controlled gene
expression (Unterstab et al., 2005). In fact, we found that P
protein could also inhibit the activation of ISRE (Fig. 2C).
Nitric oxide synthase is the key enzyme responsible for the
production of nitric oxide and nitrite can be used as the indicator
of nitric oxide production. Our results demonstrated that the
levels of nitrite production are repressed by P protein in the
presence or absence PMA and LPS stimulations (Fig. 4). These
data further suggested that the P protein of BDV inhibits iNOS
expression, and thus represses nitric oxide synthesis and nitrite
production in astrocytes.
The phosphoprotein of BDV is a central cofactor of viral RNA
synthesis that interacts with the viral RNA polymerase as well as
with the viral N and p10 proteins. We found that the region of
135aa to 174aa is essential for the inhibition of LPS and PMA-
induced activation of iNOS (Fig. 5). This region of P protein has
been reported to have several functions. The 135aa to 172aa
domain of the P protein is responsible for the oligomerization of
the viral protein and domain consisting amino acids from 135 to
182 is responsible for P protein to interact with the viral
polymerase (Schneider et al., 2004). The nuclear export activity
of BDV P protein is mediated by the sequences of MKTMMET–
MKLMMEK, which are located from amino acids 145 to 158
(Yanai et al., 2006). Our date shown in this study is consistent
with these results, which indicated that amino acids from 135 to
174 of P protein is important for the functions of the viral protein,
deletion of this region results in lose of the effect of P protein on
the inhibition of iNOS activation.
In summary, this study demonstrated that the P protein of
BDV inhibits iNOS mRNA synthesis, its protein expression,
and nitrite production induced by bacterial LPS and PMA in C6
cells. Our results also suggested that the inhibition of iNOS
activation by P protein may be due to its repression of the
activation of host transcriptional factors, such as NF-κB and
AP-1. In addition, this study provides the possibility that BDV-
infected glia cells have impaired immune responses at least in
part due to the inhibition of iNOS expression. However, the
detailed molecular mechanisms involved in the effects of BDV
on the regulation of iNOS expression and on the impaired
immune responses remain to be further investigated.
Materials and methods
Cell culture and virus propagation
C6 rat glioma cells were obtained from ATCC and main-
tained in Dulbecco's modified Eagle's medium (DMEM)
containing 10% heat-inactivated fetal bovine serum (FBS).
The BDV viral strain H1766 used for infection of C6 rat glioma
cells in this study was a gift from Dr. Ikuta of Osaka University,
Japan. In general, adherent cells were infected with a multi-
plicity of infection (MOI) of 0.1 in DMEM containing 2% FBS.
Thereafter the cells were cultured for 5 to 7 days (Bourteele et
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CO2. At 80% confluency, cells were incubated with serum-free
DMEM medium overnight prior to the incubation with 500 ng/
ml bacterial LPS and 400 ng/ml PMA based on the procedures
described previously (Syapin et al., 1999).
Plasmids construction
Plasmid pcDNA-3 and its derivatives pcDNA-P, pcDNA-N,
and pcDNA-X (expressing P, N, and p10 protein of BDV,
respectively) were kindly provided by Drs. Thorsten Wolff and
Peter Staeheli. Reporter plasmid pGLiNOS-Luc, in which the
luciferase gene was under the control of iNOS promoter, was
constructed as described previously (Gupta and Kone, 1999).
Plasmids pNF-κB-Luc, pISRE-Luc, and pAP-1-Luc containing
the luciferase gene driven by NF-κB binding element, IFN-
stimulated response element, and AP-1 recognition element,
respectively, were purchased from Stratagene. pRL-TK were
purchased from Promega.
Generation of C6 cell line stably expressing BDV P protein
C6 rat glioma cells were transfected with plasmid pcDNA3
and pcDNA-P, respectively. C6 cell lines stably expressing
BDV P protein screened with 800 μg/ml of G418 and used to
ensure transfection efficiencies.
Cell transfection and luciferase reporter gene assays
In reporter gene assays, 5×105 cells were transiently
transfected with 200 ng of the indicated reporter plasmid
along with 50 ng of the pCMV-β-gal plasmid by using
Lipofectamine 2000 (Invitrogen). To determine the activities of
viral proteins, cells were co-transfected with 400ng or the
indicated amounts of expression plasmid. Parental plasmid was
used as a control. For stimulation, cells were incubated 24 h
post-transfection with 500 ng/ml LPS and 400 ng/ml PMA and
were lysed 24 h post-stimulation in lysis buffer (Promega).
Luciferase activities were determined with the single luciferase
assay system provided by the manufacture (Promega). Values of
luciferase activity were normalized for transfection efficiency
by means of β-galactosidase that is constitutively expressed
from the plasmid pCMV-β-gal.
Semi-quantitative RT-PCR
In stably transfected or infected C6, semi-quantitative RT-
PCR for inducible nitric oxide synthase was performed with
primers (sense: 5′-CATGGCTTGCCCCTGGAAG-3′; anti-
sense: 5′-AGTGAGCTGGTAGGTTCC-3′). Amplification
was conducted in the linear range. The PCR products were
checked on 1.5% agarose gels. The images on the agarose gels
were captured electronically, and the intensity of each band was
quantified by using NIH IMAGE. The values of iNOS mRNA
were normalized by means of β-actin mRNA produced using
primers: 5′-ACCACAGTCCATGCCATCAC-3′ and 5′-TCCA-
CCACCCTGTTGCTGTA-3′.Western blot
After a 24 h incubation in the presence or absence of
different stimuli, cells were scraped off, washed with Hanks'
buffer, and homogenized in 50 mM Tris–HCl (pH7.4) contain-
ing protease inhibitors (1 mM phenylmethylsulfonyl fluoride,
5 mg/ml aprotinin, 5 mg/ml antipain, 5 mg/ml pepstatin A, and
5 mg/ml leupeptin). After electrophoresis, the proteins were
transferred onto a nitrocellulose membrane, and the iNOS
protein band was detected and visualized by immunoblotting
with antibodies against rat iNOS.
Assay for nitric oxide synthesis
Synthesis of NO was determined by measuring nitrite
production in supernatants of cell culture. Briefly, 50 μl of cell
culture supernatant was allowed to react with 50 μl of the
Sulfanilamide Solution and incubated at room temperature for
10 min, then dispense 50 μl of the NED Solution incubated at
room temperature for 10 min, protected from light. The optical
density of the assay samples was measured by spectrophoto-
metry at 550 nm. Fresh culture medium served as the blank in all
experiments. Nitrite concentrations were calculated from a
standard curve derived from the reaction of NaNO2 in the assay.
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